ETH
NAMSW icon

Exos TFP Holdings’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Exos TFP Holdings’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,273
Closed -$23.3K – 193
2023
Q3 		$23.3K Sell
12,273
-10,000
-45% -$19.4K 0.01% 136
2023
Q2 		$46.6K Sell
22,273
-71,659
-76% -$154K 0.02% 123
2023
Q1 		$173K Sell
93,932
-43,385
-32% -$68.8K 0.04% 254
2022
Q4 		$119K Buy
+137,317
New +$113K 0.03% 278

Other funds holding NAMSW

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Westchester Capital Management (New York)
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Exos TFP Holdings's NAMSW Position: Q4 2023 in Review

Exos TFP Holdings sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q4 2023, closing a stake of 12,273 shares — an estimated $23.3K sold.

Exos TFP Holdings first reported a position in NAMSW in Q4 2022 and held it in 4 quarters. The position peaked at $173K in Q1 2023. 18 funds tracked by Wall St. Rank hold NAMSW as of Q4 2023.

  • Exos TFP Holdings reported no remaining NewAmsterdam Pharma Warrant position as of Q4 2023 after selling out during the quarter.
  • Exos TFP Holdings sold 12,273 NewAmsterdam Pharma Warrant shares in Q4 2023, an estimated $23.3K.
  • Exos TFP Holdings first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 4 quarters.
  • Exos TFP Holdings's NewAmsterdam Pharma Warrant position peaked at $173K in Q1 2023.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q4 2023.

Based on Exos TFP Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.